Project Grant K99MH135172
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant of $534,191 to The Trustees of Columbia University in the City of New York (Health Sciences Division) effective April 1, 2026, through December 31, 2030, under the Mental Health Research Grants program (CFDA 93.242). This award funds the development of novel genetic discovery methodologies for neuropsychiatric traits, specifically addressing the complexity of causal variant identification...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $183,118 on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242). Under the direction of Dr. Tubbs, this research initiative will deliver integrated genomic and electronic health record (EHR) analyses designed to advance precision psychiatry by addressing critical gaps in translating genetic findings to clinical practice. The...
- The National Institute of Mental Health (NIMH) awarded a $412,500 Project Grant to Massachusetts General Hospital's Research Management Division effective September 1, 2025 through August 31, 2027, under the Mental Health Research Grants program (CFDA 93.242). The grant supports development of a copy number variant (CNV) discovery pipeline optimized for integrated genome-exome sequencing analysis. The project addresses a critical gap in neuropsychiatric research by creating computational tools...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital a Project Grant totaling $129,290 on August 22, 2025, under the Mental Health Research Grants program (CFDA 93.242). This research initiative, "Mapping Genotype to Developmental Course Across an Autism-Schizophrenia Gradient," will analyze phenotypic, genetic, and neurobiological data from over 43,000 participants and 1,900 postmortem human brain tissue donors to...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program provides $388,026 to Adelphi University to conduct research on identifying social computational phenotypes (SCPs) associated with transdiagnostic mental health spectra. The research aims to use large-scale data-driven approaches, including behavioral, computational, psychological assessment, and neuroimaging (fMRI) methods, to systematically investigate the...
- Federal Grant Award Summary The National Institute of Mental Health awarded a five-year Mentored Research Scientist Development Award of $182,851 to Massachusetts General Hospital, effective September 19, 2025 through August 31, 2030, under the Mental Health Research Grants program (CFDA 93.242). This project grant supports research aimed at identifying deficient hippocampal memory replay as a potentially treatable mechanism underlying impaired sleep-dependent memory consolidation in...
- This $1,413,000 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund research at Arizona State University (ASU) to develop a new model for identifying biocomposite clusters of stress-related psychiatric disorders (SRPDs). The key objectives are to: 1) identify epigenetic sites and brain regions most responsive to environmental factors, 2) identify genetic and endophenotype clusters that mediate the...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Johns Hopkins University a $197,640 Project Grant effective September 1, 2025 through August 31, 2030 under the Mental Health Research Grants program (CFDA 93.242). This five-year award supports an early-career investigator's research into schizophrenia-associated genetic variants in the GRIA3 gene, which encodes GluA3, a critical subunit of the AMPA receptor (Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid...
- Federal Cooperative Agreement Summary The National Institute of Mental Health awarded a $7.01 million Cooperative Agreement under the Mental Health Research Grants program (CFDA 93.242) to Massachusetts General Hospital for the SPARC-XP (Scalable Phenotyping to Assay Risk in Childhood After Exposures in Pregnancy) project. This four-year initiative (September 1, 2025 – August 31, 2029) will develop and validate predictive risk models to identify which offspring of mothers with infections...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant totaling $196,597.00 under the Mental Health Research Grants program (CFDA 93.242) to The Regents of the University of California, San Francisco, effective July 1, 2025, through June 30, 2029. This four-year research initiative investigates the neurobiological mechanisms underlying autism spectrum disorder (ASD) phenotypes, specifically examining how a high-risk ASD gene mutation produces...
WHOLE CHROMOSOME FINE-MAPPING INTEGRATING DIVERSE ANCESTRIES FOR PSYCHIATRIC DISORDERS - PROJECT SUMMARY ABSTRACT STATISTICAL FINE-MAPPING IDENTIFIES A HANDFUL OF PUTATIVE CAUSAL VARIANTS FROM HUNDREDS OF GWAS LOCI FOR PSYCHIATRIC DISORDERS, BUT CURRENT FINDINGS ARE PRIMARILY BASED ON ANALYSIS OF THE EUROPEAN COHORT, LEADING TO BIAS IN CAUSAL GENETIC VARIANT DISCOVERY AND LIMITING THE RESOLUTION OF FINDINGS. THE STATUS QUO PERSISTS DUE TO THE LACKING OF DATA AND THE UNAVAILABILITY OF SUITABLE METHODS. SEVERAL LARGE INTERNATIONAL GENETIC PROJECTS, INCLUDING PUMAS AND A-BIG-NET, HAVE RECENTLY LAUNCHED TO TARGET NON-EUROPEAN POPULATIONS AND MAKE DATA MORE ACCESSIBLE. THE ABSENCE OF PROPER FINE-MAPPING METHODS FOR POPULATIONS WITH COMPLEX GENETIC STRUCTURES IS A SIGNIFICANT HINDRANCE IN THE FIELD. THE CANDIDATE PROPOSES TO ADDRESS GAPS BETWEEN THE FORTHCOMING DATA AND APPROPRIATE METHODS BY DEVELOPING A SUITE OF OPEN-SOURCE STATISTICAL METHODS AND PUBLICLY AVAILABLE ANALYTICAL RESOURCES. THE CANDIDATE WILL: 1) DEVELOP A LOCAL-ANCESTRY-AWARE ADMIXED POPULATION FINE-MAPPING METHOD, ENABLING THE FINE-MAPPING OF ENTIRE CHROMOSOME DATA BY OPTIMIZING THE ALGORITHM AND EFFECTIVELY MANAGING MEMORY; 2) DEVELOP A BURDEN TEST APPROACH TO PRIORITIZE PUTATIVE CAUSAL GENES FOR PSYCHIATRIC DISORDERS BY FINE-MAPPING THE GENE-BASED BURDEN OF NEANDERTHAL INTROGRESSED SEQUENCES; 3) DEVELOP THE MOST INCLUSIVE FINE-MAPPING METHOD FOR PSYCHIATRIC DISORDERS BY INTEGRATING FINE-MAPPED RESULTS ACROSS DIVERSE ANCESTRIES. THE PROPOSED RESEARCH AND TRAINING PLAN WAS CAREFULLY DESIGNED TO CONFER EXPERTISE IN FOUR DOMAINS: 1) PSYCHIATRIC GENETICS AND PSYCHIATRIC PHENOTYPING, 2) STATISTICAL METHODS DEVELOPMENT AND SOFTWARE ENGINEERING, 3) LARGE-SCALE BLENDED GENOME AND EXOME (BGE) SEQUENCING DATA ANALYSIS, 4) ADMIXED POPULATION GENOMIC DATA ANALYSIS, AND 5) PROFESSIONAL DEVELOPMENT. THESE SKILLS ARE FUNDAMENTAL TO THE CANDIDATE'S GOAL OF BECOMING A LEADING INVESTIGATOR WHO DEVELOPS AND APPLIES STATISTICAL METHODS TO UNDERSTAND UNDERLYING CAUSAL GENETIC FACTORS FOR PSYCHIATRIC DISORDERS. IN ADDITION TO RESEARCH TRAINING, THE CANDIDATE WILL TAKE COURSEWORK TO GAIN GREATER EXPERTISE IN STATISTICAL METHOD DEVELOPMENT, PARTICIPATE IN REGULAR SEMINARS, ATTEND WORKSHOPS AND CONFERENCES, AND GAIN MENTORSHIP AND TEACHING EXPERIENCE. ALL RESEARCH WILL BE CONDUCTED IN THE ANALYTIC AND TRANSLATIONAL GENETICS UNIT AT MASSACHUSETTS GENERAL HOSPITAL AND THE BROAD INSTITUTE WITH MENTORSHIP FROM RENOWNED SCIENTISTS DRS. HAILIANG HUANG, TIAN GE AND JORDAN SMOLLER. ADDITIONAL GUIDANCE FROM LEADING EXPERTS DRS. BENJAMIN NEALE, KENNETH KENDLER, XIAOFENG ZHU, AND ELIZABETH ATKINSON WILL ENSURE EXCEPTIONAL GUIDANCE AND SUPPORT. OVERALL, THE TRAINING ENVIRONMENT IS OUTSTANDING, THE MENTORS AND ADVISORS ARE WORLD-CLASS, THE PROPOSED STUDIES ADDRESS AN URGENT UNMET NEED, AND THE ADDITIONAL SKILLS GAINED IN THIS AWARD WILL POISE THE CANDIDATE TO ESTABLISH INDEPENDENT LEADERSHIP IN INCLUSIVE FINE-MAPPING ANALYSIS FOR PSYCHIATRIC DISORDERS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $129.0k | 7/24/25 | ||
| Not listed | $129.3k | 7/30/24 |